Commenced in January 2007
Paper Count: 31340
An Empirical Study Comparing Industry Segments as Regards Organisation Management in Open Innovation - Based on a Questionnaire of the Pharmaceutical Industry and IT Component Industry Segment
Abstract:The aim of this research is to clarify the difference by industry segment or product characteristics as regards organisation management for an open innovation to raise R&D performance. In particular, the trait of the pharmaceutical industry is defined in comparison with IT component industry segment. In considering open innovation, both inter-organisational relation and the management in an organisation are important issues. As methodology, a questionnaire was conducted. In conclusion, suitable organisation management according to the difference in industry segment or product characteristics became clear.
Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1107511Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1342
 J.W. Scannell, A. Blanckley, H. Boldon, and B. Warrington, “Diagnosing the decline in pharmaceutical R&D efficiency,” Nature Reviews Drug Discovery, vol. 11, pp.191–200, 2012.
 Y. Suwa, “A structural change of pharmaceuticals industry segment: four shifts and three functions which bear futures”, Business Perspective from Roland Berger, vol. 87, pp.1–4, Apr. 2013.
 H. W. Chesbrough, “The era of open innovation”, Managing Innovation and Change, vol. 127, no. 3, pp. 34–41, 2006.
 K. Motohashi, Y. Ueda, and M. Mino, “The new tide of Japanese firm about the open innovation: The result and consideration of the interview survey to leading makers”, RIETI Policy Discussion Paper Series, 12-P-015, pp. 1–17, 2012.
 R. Kneller, “The importance of new companies for drug discovery: origins of a decade of new drugs,” Nature Reviews Drug Discovery, vol. 9, pp.867–882, 2010.
 Japan Health Sciences Foundation, Open innovation in drug development, HS report No.78, 2013.
 M. Sakurai and H. Kakihara, "Directed to an expansion of Japanese pharmaceutical industry", Pharmacia, vol. 49, pp. 965–969, 2013.
 K. Kakita, "Product lifecycle management (first volume)", International Drug Information, vol. 26, pp. 22–25 November, 2001.
 H. Yoshino, "DDS as part of product lifecycle management", Drug Delivery System, vol. 20, no. 6, pp.648–655, 2005.
 L. Haupt, “Vertical integration and strategic sourcing in the biopharmaceutical industry”, dissertation, Massachusetts Institute of Technology, 2005.
 A. S. C. A. D Esteves, “Technology market transfer plan-launch of DELIVES to EU market”, dissertation, Universidde Nova de Lisbosa, 2011.
 K. B. Clark, and T. Fujimoto, “Product development in the world auto industry”, Brookings Papers on Economic Activity, pp. 729–771, 1991.
 M. Iansiti, “Technology integration: Managing technological evolution in a complex environment”, Research Policy, vol. 24, pp.521–542, 1995.
 K. M. Eisenhardt and B. N. Tabrizi, “Accelerating adaptive process: Product innovation in the global computer industry”, Administrative Science Quarterly, vol. 40, pp. 84–110, 1995.
 K. Kuwajima, “Organizational capability in the research-and-development process of pharmaceutical products”, Organizational Science, vol. 33, no. 2, pp. 88–104, 1999.
 H. A Simon, “The science of design: creating the artificial”, Design Issues, pp.67–82, 1988.
 T. Fujimoto, and M. Yasumoto, “A Comparison of Effective Product Development Pattern across Multi-Industries -Results of a Questionnaire Survey in 203 Product Development Organizations”, CIRJE-J-7, 1998.
 W. M. Cohen and D. A. Levinthal, “Absorptive capacity: a new perspective on learning and innovation”, Administrative Science Quarterly, pp. 128–152, 1990.
 R. Henderson and I. Cockburn, “Measuring competence? Exploring firm effects in pharmaceutical research”, Strategic Management Journal, vol. 15, pp. 63–84, 1994.
 D. Aloini, and A. Martini, “Exploring the exploratory search for innovation: a structural equation modelling test for practices and performance”, International Journal of Technology Management, vol. 61, no.1, pp.23–46, 2013.
 Y. Hamaoka, "The determinant factor of the results of inbound, outbound open innovation", in Annual Conference Proceedings of Japan Society for Science Policy and Research Management, 27, 2012, pp.1017–1022.
 N. Takahashi, K. Kuwajima, and M. Tamada, "Research-and-development performance and gatekeeper", CIRJE-J-67, 2002.
 H. Huang, “Technological learning and technological innovation creation: An empirical analysis of biotechnology R&D Teams”, Journal of Engineering Science and Technology Review, vol. 6, no. 2, pp.120–124, 2013.
 A. Oke, D. I. Prajogo, and I. Jayaram, “Strengthening the innovation chain: The role of internal innovation climate and strategic relationships with supply chain partners”, Supply Chain Management, vol. 49, no. 4, pp. 43–58, 2013.
 H. Shiraishi, "The essence of dynamic capability – case study of Kao and Dai Nippon Printing”, Journal of Information and Management, vol. 29, no. 4, pp. 72–83, 2009.
 A. Takeshi, “The division of work between companies and innovation: From the viewpoint of a division of knowledge", IIR Working Paper, pp. 1–10, Sep. 2001.